Formation of nanosuspensions in bottom-up approach: theories and optimization
Tóm tắt
Từ khóa
Tài liệu tham khảo
Esfandi E, Ramezani V, Vatanara A, Najafabadi AR, Moghaddam SPH. Clarithromycin dissolution enhancement by preparation of aqueous nanosuspensions using sonoprecipitation technique. Iran J Pharm Res. 2014;13(3):809–18.
Verma S, Gokhale R. Burgess DJ. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions. Int J Pharm. 2009;380(1–2):216–22.
Bolourchian N, Mahboobian MM, Dadashzadeh S. The effect of PEG molecular weights on dissolution behavior of simvastatin in solid dispersions. Iran J Pharm Res. 2013;12(Suppl):11–20.
Saeedi M, Akbari J, Morteza-Semnani K, Enayati-Fard R, Sar-Reshteh-dar S, Soleymani A. Enhancement of dissolution rate of indomethacin using liquisolid compacts. Iran J Pharm Res. 2010:25–33.
Lipinski C. Poor aqueous solubility—an industry wide problem in drug discovery. Am Pharm Rev. 2002;5(3):82–5.
Patravale VB, Date AA, Kulkarni RM. Nanosuspensions: a promising drug delivery strategy. J Pharm Pharmacol. 2004;56(7):827–40.
Kesisoglou F, Panmai S, Wu YH. Nanosizing - Oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev. 2007;59(7):631–44.
Jacobs C, Muller RH. Production and characterization of a budesonide nanosuspension for pulmonary administration. Pharm Res. 2002;19(2):189–94.
Muller RH, Gohla S, Keck CM. State of the art of nanocrystals - special features, production, nanotoxicology aspects and intracellular delivery. Eur J Pharm Biopharm. 2011;78(1):1–9.
Mauludin R, Muller RH, Keck CM. Kinetic solubility and dissolution velocity of rutin nanocrystals. Eur J Pharm Sci. 2009;36(4–5):502–10.
Müller RH, Akkar A. Drug nanocrystals of poorly soluble drugs. Encyclopedia of nanoscience and nanotechnology. 2. American Scientific Publishers; 2004. p. 627–38.
Sun J, Wang F, Sui Y, She Z, Zhai W, Wang C, et al. Effect of particle size on solubility, dissolution rate, and oral bioavailability: evaluation using coenzyme Q10 as naked nanocrystals. Int J Nanomedicine. 2012;7:5733.
Müller RH, Peters K. Nanosuspensions for the formulation of poorly soluble drugs: I. preparation by a size-reduction technique. Int J Pharm. 1998;160(2):229–37.
Müller RH, Benita S, Böhm BH. Emulsions and nanosuspensions for the formulation of poorly soluble drugs. Boca Raton: CRC Press; 1998.
Müller R, Jacobs C, Kayser O. Nanosuspensions for the formulation of poorly soluble drugs. Pharmaceutical emulsions and suspensions: Second Edition, REVISED AND EXPANDED. Boca Raton: CRC Press; 2000. p. 383–407.
Muller RH, Jacobs C, Kayser O. Nanosuspensions as particulate drug formulations in therapy rationale for development and what we can expect for the future. Adv Drug Deliv Rev. 2001;47(1):3–19.
Müller RH, Jacobs C, Kayser O. DissoCubes‚ a novel formulation for poorly soluble and poorly bioavailable drugs. modified-release drug delivery technology. Informa Healthcare; 2002. p. 135–49.
Merisko-Liversidge E, Liversidge GG, Cooper ER. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur J Pharm Sci. 2003;18(2):113–20.
Peters K, Leitzke S, Diederichs JE, Borner K, Hahn H, Muller RH, et al. Preparation of a clofazimine nanosuspension for intravenous use and evaluation of its therapeutic efficacy in murine Mycobacterium avium infection. J Antimicrob Chemother. 2000;45(1):77–83.
Samei M, Vatanara A, Fatemi S, Najafabadi AR. Process variables in the formation of nanoparticles of megestrol acetate through rapid expansion of supercritical CO 2. J Supercrit Fluids. 2012;70:1–7.
Sofie V, Jan V, Ludo F, Patrick A. Microcrystalline cellulose, a useful alternative for sucrose as a matrix former during freeze-drying of drug nanosuspensions–a case study with itraconazole. Eur J Pharm Biopharm. 2008;70(2):590–6.
Lai F, Pireddu R, Corrias F, Fadda AM, Valenti D, Pini E, et al. Nanosuspension improves tretinoin photostability and delivery to the skin. Int J Pharm. 2013;458(1):104–9.
Möschwitzer JP. Drug nanocrystals in the commercial pharmaceutical development process. Int J Pharm. 2013;453(1):142–56.
Moschwitzer J, Achleitner G, Pomper H, Muller RH. Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology. Eur J Pharm Biopharm. 2004;58(3):615–9.
Li M, Azad M, Dave R, Bilgili E. Nanomilling of drugs for bioavailability enhancement: a holistic formulation-process perspective. Pharmaceutics. 2016;8(2):17.
Wagener P, Lau M, Breitung-Faes S, Kwade A, Barcikowski S. Physical fabrication of colloidal ZnO nanoparticles combining wet-grinding and laser fragmentation. Applied Physics A. 2012;108(4):793–9.
Habiba K, Makarov VI, Weiner BR, Morell G. Fabrication of nanomaterials by pulsed laser synthesis. Manufacturing Nanostructures. Manchester, UK: One Central Press; 2014.
Liu P. Nanocrystal formulation for poorly soluble. Drugs. 2013.
Loh ZH, Samanta AK, Heng PWS. Overview of milling techniques for improving the solubility of poorly water-soluble drugs. Asian Journal of Pharmaceutical Sciences. 2015;10(4):255–74.
Huttenrauch R, Fricke S, Zielke P. Mechanical activation of pharmaceutical systems. Pharm Res. 1985;2(6):302–6.
Verma S, Lan Y, Gokhale R, Burgess DJ. Quality by design approach to understand the process of nanosuspension preparation. Int J Pharm. 2009;377(1–2):185–98.
Xiong R, Lu W, Li J, Wang P, Xu R, Chen T. Preparation and characterization of intravenously injectable nimodipine nanosuspension. Int J Pharm. 2008;350(1–2):338–43.
Ghosh I, Bose S, Vippagunta R, Harmon F. Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth. Int J Pharm. 2011;409(1–2):260–8.
Sinha B, Muller RH, Moschwitzer JP. Bottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle size. Int J Pharm. 2013;453(1):126–41.
Chan HK, Kwok PCL. Production methods for nanodrug particles using the bottom-up approach. Adv Drug Deliv Rev. 2011;63(6):406–16.
Date AA, Patravale VB. Current strategies for engineering drug nanoparticles. Curr Opin Colloid Interface Sci. 2004;9(3–4):222–35.
Dirksen JA, Ring TA. Fundamentals of crystallization - kinetic effects on particle-size distributions and morphology. Chem Eng Sci. 1991;46(10):2389–427.
Chen A, Shi Y, Yan Z, Hao H, Zhang Y, Zhong J, et al. Dosage form developments of nanosuspension drug delivery system for oral administration route. Curr Pharm Des. 2015;21(29):4355–65.
Du J, Li X, Zhao H, Zhou Y, Wang L, Tian S, et al. Nanosuspensions of poorly water-soluble drugs prepared by bottom-up technologies. Int J Pharm. 2015;495(2):738–49.
Shegokar R, Müller RH. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. Int J Pharm. 2010;399(1–2):129–39.
Hu J, Ng WK, Dong Y, Shen S, Tan RB. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying. Int J Pharm. 2011;404(1–2):198–204.
Quan P, Xia D, Piao H, Piao H, Shi K, Jia Y, et al. Nitrendipine nanocrystals: its preparation, characterization, and in vitro–in vivo evaluation. AAPS PharmSciTech. 2011;12(4):1136–43.
Kurakula M, El-Helw AM, Sobahi TR, Abdelaal MY. Chitosan based atorvastatin nanocrystals: effect of cationic charge on particle size, formulation stability, and in-vivo efficacy. Int J Nanomedicine. 2015;10:321–34.
Lu Y, Wang ZH, Li T, McNally H, Park K, Sturek M. Development and evaluation of transferrin-stabilized paclitaxel nanocrystal formulation. J Control Release. 2014;176:76–85.
Lindfors L, Forssen S, Westergren J, Olsson U. Nucleation and crystal growth in supersaturated solutions of a model drug. J Colloid Interface Sci. 2008;325(2):404–13.
LaMer VK, Dinegar RH. Theory, production and mechanism of formation of monodispersed hydrosols. J Am Chem Soc. 1950;72(11):4847–54.
Lindfors L, Skantze P, Skantze U, Westergren J, Olsson U. Amorphous drug nanosuspensions. 3. Particle dissolution and crystal growth. Langmuir. 2007;23(19):9866–74.
Garrick S, Lehtinen K, Zachariah M. Nanoparticle coagulation via a Navier–stokes/nodal methodology: evolution of the particle field. J Aerosol Sci. 2006;37(5):555–76.
Huang F, Zhang HZ, Banfield JF. Two-stage crystal-growth kinetics observed during hydrothermal coarsening of nanocrystalline ZnS. Nano Lett. 2003;3(3):373–8.
Bilecka I, Elser P, Niederberger M. Kinetic and thermodynamic aspects in the microwave-assisted synthesis of ZnO nanoparticles in benzyl alcohol. ACS Nano. 2009;3(2):467–77.
Raghavan SL, Trividic A, Davis AF, Hadgraft J. Crystallization of hydrocortisone acetate: influence of polymers. Int J Pharm. 2001;212(2):213–21.
Kwon SG, Hyeon T. Formation mechanisms of uniform nanocrystals via hot-injection and heat-up methods. Small. 2011;7(19):2685–702.
Verma S, Kumar S, Gokhale R, Burgess DJ. Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening. Int J Pharm. 2011;406(1–2):145–52.
Ribeiro C, Lee EJ, Longo E. Leite ER. A kinetic model to describe nanocrystal growth by the oriented attachment mechanism. ChemPhysChem. 2005;6(4):690–6.
Viswanatha R, Santra PK, Dasgupta C, Sarma DD. Growth mechanism of nanocrystals in solution: ZnO, a case study. Phys Rev Lett. 2007;98(25):255501.
Cabane H, Laporte D, Provost A. An experimental study of Ostwald ripening of olivine and plagioclase in silicate melts: implications for the growth and size of crystals in magmas. Contrib Mineral Petrol. 2005;150(1):37–53.
Solomatov VS, Stevenson DJ. Kinetics of crystal-growth in a terrestrial Magma Ocean. Journal of Geophysical Research-Planets. 1993;98(E3):5407–18.
Schram CJ, Smyth RJ, Taylor LS, Beaudoin SP. Understanding crystal Growth kinetics in the absence and presence of a polymer using a rotating disk apparatus. Cryst Growth Des. 2016;16(5):2640–5.
Thanh NT, Maclean N, Mahiddine S. Mechanisms of nucleation and growth of nanoparticles in solution. Chem Rev. 2014;114(15):7610–30.
Kashchiev D. Nucleation: basic theory with applications. Boston: Butterworth Heinemann; 2000.
Lee H, Lee J. Dissolution enhancement of celecoxib via polymer-induced crystallization. J Cryst Growth. 2013;374:37–42.
Somasundaran P, Huang L. Adsorption/aggregation of surfactants and their mixtures at solid-liquid interfaces. Adv Colloid Interf Sci. 2000;88(1–2):179–208.
Grau MJ, Kayser O, Muller RH. Nanosuspensions of poorly soluble drugs - reproducibility of small scale production. Int J Pharm. 2000;196(2):155–9.
Lee J. Drug nano-and microparticles processed into solid dosage forms: physical properties. J Pharm Sci. 2003;92(10):2057–68.
Berglund KD, Przybycien TM, Tilton RD. Coadsorption of sodium dodecyl sulfate with hydrophobically modified nonionic cellulose polymers. 1. Role of polymer hydrophobic modification. Langmuir. 2003;19(7):2705–13.
Lee J, Lee SJ, Choi JY, Yoo JY, Ahn CH. Amphiphilic amino acid copolymers as stabilizers for the preparation of nanocrystal dispersion. Eur J Pharm Sci. 2005;24(5):441–9.
Muller RH, Jacobs C. Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability. Int J Pharm. 2002;237(1–2):151–61.
Kronberg B, Stenius P. The effect of surface polarity on the adsorption of nonionic surfactants. I Thermodynamic considerations. J Colloid Interface Sci. 1984;102(2):410–7.
Zheng H, Smith RK, Jun YW, Kisielowski C, Dahmen U, Alivisatos AP. Observation of single colloidal platinum nanocrystal growth trajectories. Science. 2009;324(5932):1309–12.
Harris MT, Byers CH. Effect of solvent on the homogeneous precipitation of Titania by titanium Ethoxide hydrolysis. J Non-Cryst Solids. 1988;103(1):49–64.
Clark MD. Growth laws for surfactant-coated nanocrystals: Ostwald ripening and size focusing. J Nanopart Res. 2014;16(2):2264.
Burlakov V. Ostwald ripening on nanoscale. arXiv preprint arXiv:07105224. 2007.
Niederberger M, Colfen H. Oriented attachment and mesocrystals: non-classical crystallization mechanisms based on nanoparticle assembly. Phys Chem Chem Phys. 2006;8(28):3271–87.
Liu Z, Wen XD, Wu XL, Gao YJ, Chen HT, Zhu J, et al. Intrinsic dipole-field-driven mesoscale crystallization of core-shell ZnO mesocrystal microspheres. J Am Chem Soc. 2009;131(26):9405–12.
Privman VV, Goia DV, Park J, Matijevi cacute E. Mechanism of formation of monodispersed colloids by aggregation of nanosize precursors. J Colloid Interface Sci. 1999;213(1):36–45.
Colfen H, Mann S. Higher-order organization by mesoscale self-assembly and transformation of hybrid nanostructures. Angew Chem Int Ed Engl. 2003;42(21):2350–65.
Ain-Ai A, Gupta PK. Effect of arginine hydrochloride and hydroxypropyl cellulose as stabilizers on the physical stability of high drug loading nanosuspensions of a poorly soluble compound. Int J Pharm. 2008;351(1–2):282–8.
Dharmalingam SR, Chidambaram K, Ramamurthy S, Nadaraju S. Effects of nanosuspension and inclusion complex techniques on the in vitro protease inhibitory activity of naproxen. Braz J Pharm Sci. 2014;50(1):165–71.
Mura P, Maestrelli F, Cirri M. Ternary systems of naproxen with hydroxypropyl-β-cyclodextrin and aminoacids. Int J Pharm. 2003;260(2):293–302.
Sugimoto T, Shiba F, Sekiguchi T, Itoh H. Spontaneous nucleation of monodisperse silver halide particles from homogeneous gelatin solution I: silver chloride. Colloids Surf A Physicochem Eng Asp. 2000;164(2–3):183–203.
Lifshitz IM, Slyozov VV. The kinetics of precipitation from supersaturated solid solutions. J Phys Chem Solids. 1961;19(1–2):35–50.
Wagner C. Theorie der alterung von niederschlägen durch umlösen (Ostwald-reifung). Zeitschrift für Elektrochemie, Berichte der Bunsengesellschaft für physikalische Chemie. 1961;65(7–8):581–91.
Papdiwal AP, Pande VV, Aher S. Investigation of effect of different stabilizers on formulation of zaltoprofen nanosuspension. Int J Pharm Sci Rev Res. 2014;27(2):244–9.
Lee W-R, Kim MG, Choi J-R, Park J-I, Ko SJ, Oh SJ, et al. Redox− transmetalation process as a generalized synthetic strategy for core− shell magnetic nanoparticles. J Am Chem Soc. 2005;127(46):16090–7.
Watzky MA, Finke RG. Transition metal nanocluster formation kinetic and mechanistic studies. A new mechanism when hydrogen is the reductant: slow, continuous nucleation and fast autocatalytic surface growth. J Am Chem Soc. 1997;119(43):10382–400.
Daebis NAO, El-Massik M, Abdelkader H. Formulation and characterization of Itraconazole Oral Nanosuspension: methyl cellulose as promising stabilizer. Ely J Pharm Res. 2015;1(1):102.
Xia D, Ouyang M, Wu JX, Jiang Y, Piao H, Sun S, et al. Polymer-mediated anti-solvent crystallization of nitrendipine: monodispersed spherical crystals and growth mechanism. Pharm Res. 2012;29(1):158–69.
Peng X, Manna L, Yang W, Wickham J, Scher E, Kadavanich A, et al. Shape control of CdSe nanocrystals. Nature. 2000;404(6773):59–61.
Peng ZA, Peng XG. Nearly monodisperse and shape-controlled CdSe nanocrystals via alternative routes: nucleation and growth. J Am Chem Soc. 2002;124(13):3343–53.
Lindfors L, Skantze P, Skantze U, Rasmusson M, Zackrisson A, Olsson U. Amorphous drug nanosuspensions. 1 Inhibition of Ostwald ripening. Langmuir. 2006;22(3):906–10.
Lindfors L, Forssen S, Skantze P, Skantze U, Zackrisson A, Olsson U. Amorphous drug nanosuspensions. 2. Experimental determination of bulk monomer concentrations. Langmuir. 2006;22(3):911–6.
Mullin JW. Crystallization: Butterworth-Heinemann; 2001.
Penn RL, Oskam G, Strathmann TJ, Searson PC, Stone AT, Veblen DR. Epitaxial assembly in aged colloids. J Phys Chem B. 2001;105(11):2177–82.
Kulak AN, Iddon P, Li Y, Armes SP, Colfen H, Paris O, et al. Continuous structural evolution of calcium carbonate particles: a unifying model of copolymer-mediated crystallization. J Am Chem Soc. 2007;129(12):3729–36.
Andreassen JP. Formation mechanism and morphology in precipitation of vaterite - nano aggregation or crystal growth? J Cryst Growth. 2005;274(1–2):256–64.
Shen Q, Wei H, Wang L, Zhou Y, Zhao Y, Zhang Z, et al. Crystallization and aggregation behaviors of calcium carbonate in the presence of poly(vinylpyrrolidone) and sodium dodecyl sulfate. J Phys Chem B. 2005;109(39):18342–7.
Sugimoto T, Dirige GE, Muramatsu A. Formation mechanism of monodisperse CdS particles from concentrated solutions of Cd-EDTA complexes. J Colloid Interface Sci. 1996;182(2):444–56.
Ali HSM, York P, Blagden N. Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors. Int J Pharm. 2009;375(1–2):107–13.
Heng JY, Thielmann F, Williams DR. The effects of milling on the surface properties of form I paracetamol crystals. Pharm Res. 2006;23(8):1918–27.
Lai F, Sinico C, Ennas G, Marongiu F, Marongiu G, Fadda AM. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour. Int J Pharm. 2009;373(1–2):124–32.
Dong Y, Chang YJ, Wang Q, Tong J, Zhou J. Effects of surfactants on size and structure of amylose nanoparticles prepared by precipitation. Bull Mater Sci. 2016;39(1):35–9.
Dolenc A, Kristl J, Baumgartner S, Planinsek O. Advantages of celecoxib nanosuspension formulation and transformation into tablets. Int J Pharm. 2009;376(1–2):204–12.
Kumar R, Siril PF. Controlling the size and morphology of griseofulvin nanoparticles using polymeric stabilizers by evaporation-assisted solvent-antisolvent interaction method. J Nanopart Res. 2015;17(6):256.
Tran TT, Tran PH, Nguyen MN, Tran KT, Pham MN, Tran PC, et al. Amorphous isradipine nanosuspension by the sonoprecipitation method. Int J Pharm. 2014;474(1–2):146–50.
Hecq J, Deleers M, Fanara D, Vranckx H, Amighi K. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine. Int J Pharm. 2005;299(1–2):167–77.
Saindane NS, Pagar KP, Vavia PR. Nanosuspension based in situ gelling nasal spray of carvedilol: development, in vitro and in vivo characterization. AAPS PharmSciTech. 2013;14(1):189–99.
Sato T, Takeuchi H, Sakurai T, Tanaka K, Matsuki K, Higashi K, et al. Characterization of a riboflavin non-aqueous nanosuspension prepared by bead milling for cutaneous application. Chem Pharm Bull (Tokyo). 2015;63(2):88–94.
Chari K, Antalek B, Kowalczyk J, Eachus RS, Chen T. Polymer− surfactant interaction and stability of amorphous colloidal particles. J Phys Chem B. 1999;103(45):9867–72.
Matteucci ME, Hotze MA, Johnston KP, Williams RO III. Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization. Langmuir. 2006;22(21):8951–9.
Jongen N, Bowen P, Lemaitre J, Valmalette JC, Hofmann H. Precipitation of self-organized copper oxalate polycrystalline particles in the presence of hydroxypropylmethylcellulose (HPMC): control of morphology. J Colloid Interface Sci. 2000;226(2):189–98.
Kronberg B, Lindman B. Surfactants and polymers in aqueous solution. Chichester: John Wiley & Sons Ltd.; 2003.
Kumar MP, Rao YM, Apte S. Formulation of nanosuspensions of albendazole for oral administration. Curr Nanosci. 2008;4(1):53–8.
Ruiz-Cabello FJ, Trefalt G, Csendes Z, Sinha P, Oncsik T, Szilagyi I, et al. Predicting aggregation rates of colloidal particles from direct force measurements. J Phys Chem B. 2013;117(39):11853–62.
Lyklema J. Principles of the stability of lyophobic colloidal dispersions in non-aqueous media. Adv Colloid Interf Sci. 1968;2(2):67–114.
Zhao YX, Hua HY, Chang M, Liu WJ, Zhao Y, Liu HM. Preparation and cytotoxic activity of hydroxycamptothecin nanosuspensions. Int J Pharm. 2010;392(1–2):64–71.
Van Eerdenbrugh B, Vermant J, Martens JA, Froyen L, Van Humbeeck J, Augustijns P, et al. A screening study of surface stabilization during the production of drug nanocrystals. J Pharm Sci. 2009;98(6):2091–103.
Singare DS, Giriraj TK, Gowthamrajan K. Nanosuspension solidification technique: evaluation of high shear granulation as per industrial perspective.
Van Eerdenbrugh B, Van den Mooter G, Augustijns P. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int J Pharm. 2008;364(1):64–75.
Jacobs C, Kayser O, Muller RH. Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide. Int J Pharm. 2000;196(2):161–4.
Müller RH, Hildebrand GE. Zetapotential und Partikelladung in der Laborpraxis(Einführung in die Theorie praktische Messdurchführung Dateninterpretation). Paperback APV; 1996.
Freitas C, Muller RH. Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN (TM)) dispersions. Int J Pharm. 1998;168(2):221–9.
Manciu M, Ruckenstein E. Role of the hydration force in the stability of colloids at high ionic strengths. Langmuir. 2001;17(22):7061–70.
Van der Hoeven PC, Lyklema J. Electrostatic stabilization in non-aqueous media. Adv Colloid Interf Sci. 1992;42:205–77.
Tuomela A, Hirvonen J, Peltonen L. Stabilizing agents for drug nanocrystals: effect on bioavailability. Pharmaceutics. 2016;8(2):16.
George M, Ghosh I. Identifying the correlation between drug/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology. Eur J Pharm Sci. 2013;48(1–2):142–52.
Peltonen L, Hirvonen J. Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods. J Pharm Pharmacol. 2010;62(11):1569–79.
Zhang H, Hollis CP, Zhang Q, Li T. Preparation and antitumor study of camptothecin nanocrystals. Int J Pharm. 2011;415(1–2):293–300.
Attard P, Antelmi D, Larson I. Comparison of the zeta potential with the diffuse layer potential from charge titration. Langmuir. 2000;16(4):1542–52.
Bourikas K, Stylidi M, Kondarides DI, Verykios XE. Adsorption of acid orange 7 on the surface of titanium dioxide. Langmuir. 2005;21(20):9222–30.
Kim TH, Choi SM, Kline SR. Polymerized rodlike nanoparticles with controlled surface charge density. Langmuir. 2006;22(6):2844–50.
Liao D, Wu G, Liao B. Zeta potential of shape-controlled TiO 2 nanoparticles with surfactants. Colloids Surf A Physicochem Eng Asp. 2009;348(1):270–5.
Tanaka Y, Inkyo M, Yumoto R, Nagai J, Takano M, Nagata S. Nanoparticulation of poorly water soluble drugs using a wet-mill process and physicochemical properties of the nanopowders. Chem Pharm Bull. 2009;57(10):1050–7.
Raghavan SL, Schuessel K, Davis A, Hadgraft J. Formation and stabilisation of triclosan colloidal suspensions using supersaturated systems. Int J Pharm. 2003;261(1–2):153–8.
Ziller KH, Rupprecht HH. Control of crystal-Growth in drug suspensions .2. Influence of polymers on dissolution and crystallization during temperature cycling. Pharmazeutische Industrie. 1990;52(8):1017–22.
Teeranachaideekul V, Junyaprasert VB, Souto EB, Muller RH. Development of ascorbyl palmitate nanocrystals applying the nanosuspension technology. Int J Pharm. 2008;354(1–2):227–34.
Choi JY, Yoo JY, Kwak HS, Nam BU, Lee J. Role of polymeric stabilizers for drug nanocrystal dispersions. Curr Appl Phys. 2005;5(5):472–4.
Walstra P. Formation of emulsions. 1983.
Müller RH. Colloidal carriers for controlled drug delivery and targeting: modification, characterization and in vivo distribution. London: Taylor & Francis; 1991.
Liu P, Rong X, Laru J, van Veen B, Kiesvaara J, Hirvonen J, et al. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling. Int J Pharm. 2011;411(1–2):215–22.
Wegner G, Baum P, Müller M, Norwig J, Landfester K (eds). Polymers designed to control nucleation and growth of inorganic crystals from aqueous media. Macromolecular Symposia. Wiley Online Library; 2001.
Shenoy DB, Sukhorukov GB. Engineered microcrystals for direct surface modification with layer-by-layer technique for optimized dissolution. Eur J Pharm Biopharm. 2004;58(3):521–7.
Giermanska-Kahn J, Schmitt V, Binks BP. Leal-Calderon F. A new method to prepare monodisperse Pickering emulsions. Langmuir. 2002;18(7):2515–8.
Keck CM, Muller RH. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur J Pharm Biopharm. 2006;62(1):3–16.
Zimmermann E, Muller RH. Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle (SLN (TM)) dispersions in artificial gastrointestinal media. Eur J Pharm Biopharm. 2001;52(2):203–10.
Einarson MB, Berg JC. Electrosteric stabilization of colloidal latex dispersions. J Colloid Interface Sci. 1993;155(1):165–72.
Shete G, Jain H, Punj D, Prajapat H, Akotiya P, Bansal AK. Stabilizers used in nanocrystal based drug delivery systems. Journal of Excipients and Food Chemicals. 2014;5(4):184–209.
Verma S, Huey BD, Burgess DJ. Scanning probe microscopy method for nanosuspension stabilizer selection. Langmuir. 2009;25(21):12481–7.
Jiang T, Han N, Zhao B, Xie Y, Wang S. Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation. Drug Dev Ind Pharm. 2012;38(10):1230–9.
Berglund KD, Przybycien TM, Tilton RD. Coadsorption of sodium dodecyl sulfate with hydrophobically modified nonionic cellulose polymers. 2. Role of surface selectivity in adsorption hysteresis. Langmuir. 2003;19(7):2714–21.
Tanvir S, Qiao L. Surface tension of Nanofluid-type fuels containing suspended nanomaterials. Nanoscale Res Lett. 2012;7(1):226.
Jackson KA. Kinetic Processes: Crystal Growth, Diffusion, and phase transformations in materials. Hoboken: Wiley; 2006.
Wong EM, Bonevich JE, Searson PC. Growth kinetics of nanocrystalline ZnO particles from colloidal suspensions. J Phys Chem B. 1998;102(40):7770–5.
Oskam G, Nellore A, Penn RL, Searson PC. The growth kinetics of TiO2 nanoparticles from titanium(IV) alkoxide at high water/titanium ratio. J Phys Chem B. 2003;107(8):1734–8.
Dalvi SV, Dave RN. Controlling particle size of a poorly water-soluble drug using ultrasound and stabilizers in antisolvent precipitation. Ind Eng Chem Res. 2009;48(16):7581–93.
Monnier H, Wilhelm AM, Delmas H. Influence of ultrasound on mixing on the molecular scale for water and viscous liquids. Ultrason Sonochem. 1999;6(1–2):67–74.
O'Connor SM, Gehrke SH. Synthesis and characterization of thermally-responsive hydroxypropyl methylcellulose gel beads. J Appl Polym Sci. 1997;66(7):1279–90.
Zhang ZP, Tan SW, Feng SS. Vitamin E TPGS as a molecular biomaterial for drug delivery. Biomaterials. 2012;33(19):4889–906.
Shanbhag A, Rabel S, Nauka E, Casadevall G, Shivanand P, Eichenbaum G, et al. Method for screening of solid dispersion formulations of low-solubility compounds - miniaturization and automation of solvent casting and dissolution testing. Int J Pharm. 2008;351(1–2):209–18.
Jeyachandran YL, Mielczarski E, Rai B, Mielczarski JA. Quantitative and qualitative evaluation of adsorption/desorption of bovine serum albumin on hydrophilic and hydrophobic surfaces. Langmuir. 2009;25(19):11614–20.
Seo JH, Dembereldorj U, Park J, Kim M, Kim S, Joo SW. Facile internalization of paclitaxel on titania nanoparticles in human lung carcinoma cells after adsorption of serum proteins. J Nanopart Res. 2012;14(10):1–8.
Niwa T, Danjo K. Design of self-dispersible dry nanosuspension through wet milling and spray freeze-drying for poorly water-soluble drugs. Eur J Pharm Sci. 2013;50(3–4):272–81.
Pongpeerapat A, Wanawongthai C, Tozuka Y, Moribe K, Yamamoto K. Formation mechanism of colloidal nanoparticles obtained from probucol/PVP/SDS ternary ground mixture. Int J Pharm. 2008;352(1–2):309–16.
Mou D, Chen H, Wan J, Xu H, Yang X. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility. Int J Pharm. 2011;413(1–2):237–44.
Gao L, Liu G, Ma J, Wang X, Wang F, Wang H, et al. Paclitaxel nanosuspension coated with P-gp inhibitory surfactants: II. Ability to reverse the drug-resistance of H460 human lung cancer cells. Colloids Surf B: Biointerfaces. 2014;117:122–7.
Rowe RC, Sheskey PJ, Weller PJ. Handbook of pharmaceutical excipients. London: Pharmaceutical press; 2006.
Rajebahadur M, Zia H, Nues A, Lee C. Mechanistic study of solubility enhancement of nifedipine using vitamin E TPGS or solutol HS-15. Drug Deliv. 2006;13(3):201–6.
Delongeas JL, de Conchard GV, Beamonte A, Bertheux H, Spire C, Maisonneuve C, et al. Assessment of Labrasol (R)/Labrafil (R)/Transcutol (R) (4/4/2, v/v/v) as a non-clinical vehicle for poorly water-soluble compounds after 4-week oral toxicity study in Wistar rats. Regul Toxicol Pharmacol. 2010;57(2–3):284–90.
Adamson AW, Gast AP. Physical chemistry of surfaces. 1967.
Ghosh I, Schenck D, Bose S, Ruegger C. Optimization of formulation and process parameters for the production of nanosuspension by wet media milling technique: effect of vitamin E TPGS and nanocrystal particle size on oral absorption. Eur J Pharm Sci. 2012;47(4):718–28.
Dalvi SV, Dave RN. Analysis of nucleation kinetics of poorly water-soluble drugs in presence of ultrasound and hydroxypropyl methyl cellulose during antisolvent precipitation. Int J Pharm. 2010;387(1–2):172–9.
Obeidat WM, Sallam A-SA. Evaluation of tadalafil nanosuspensions and their PEG solid dispersion matrices for enhancing its dissolution properties. AAPS PharmSciTech. 2014;15(2):364–74.
Romero-Cano MS, Martin-Rodriguez A, de las Nieves FJ. Electrosteric stabilization of polymer colloids with different functionality. Langmuir. 2001;17(11):3505–11.
Don TM, Hsu SC, Chiu WY. Structures and thermal properties of chitosan-modified poly (methyl methacrylate). J Polym Sci A Polym Chem. 2001;39(10):1646–55.
Niwa T, Miura S, Danjo K. Universal wet-milling technique to prepare oral nanosuspension focused on discovery and preclinical animal studies - development of particle design method. Int J Pharm. 2011;405(1–2):218–27.
Detroja C, Chavhan S, Sawant K. Enhanced antihypertensive activity of candesartan cilexetil nanosuspension: formulation, characterization and pharmacodynamic study. Sci Pharm. 2011;79(3):635–51.
Chen XX, Young TJ, Sarkari M, Williams RO, Johnston KP. Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution. Int J Pharm. 2002;242(1–2):3–14.
Sarkari M, Brown J, Chen XX, Swinnea S, Williams RO, Johnston KP. Enhanced drug dissolution using evaporative precipitation into aqueous solution. Int J Pharm. 2002;243(1–2):17–31.
Abdelwahed W, Degobert G, Fessi H. Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage. Eur J Pharm Biopharm. 2006;63(2):87–94.
Elham G, Mahsa P, Vatanara A, Vahid R. Spray drying of nanoparticles to form fast dissolving glipizide. Asian Journal of Pharmaceutics. 2015;9(3):213–8.